Contact
Please use this form to send email to PR contact of this press release:
Senex Publication Reveals the Importance of CDK8/19 Inhibition as Treatment for Castration Resistant Prostate Cancer
TO:
Dennis I Goldberg
Senex Biotechnology, Inc.
+1 508-878-7589